Skip to main content
Clinical Trials/ACTRN12613000365763
ACTRN12613000365763
Completed
未知

The development of a quality of life instrument specific to the treatment effects in autoimmune bullous disease: the Treatment Autoimmune Bullous Disease Quality of Life instrument (TABQOL)

Australasian Blistering Diseases Foundation0 sites70 target enrollmentApril 5, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
Quality of Life in Autoimmune Bullous Disease
Sponsor
Australasian Blistering Diseases Foundation
Enrollment
70
Status
Completed
Last Updated
6 years ago